ip articles

Pharmaceutical Patents in South America: Registering Patents in Brazil is Going to be Easierip articles
25 May 2018

Pharmaceutical Patents in South America: Registering Patents in Brazil is Going to be Easier

by Moeller IP Advisors Brazil is one of the biggest pharmaceutical markets in the world. IMS Health -a pharmaceutical consulting and information company- estimated that the Brazilian market will achieve around 40 billions of US dollars in 2017, in pharmaceutical sales. From 2007 to 2011, the market grew an astounding 82%, according to a report […]

Patent Linkage System in Chileip articles
24 May 2018

The Patent Linkage System in Chile

By Moeller IP Advisors Research and Development of pharmaceutical products is an extremely capital intensive activity. It takes an average 10 of years for a new drug to be developed, tested and commercialized; only one out of five thousand drugs are approved for human testing and among these, only one out of five makes it […]

Patentability of Embryonic Stem Cells in Mexicoip articles
23 May 2018

Patentability of Embryonic Stem Cells in Mexico

By Moeller IP Advisors Stem cells have the potential to treat a wide range of diseases and constitute a key research tool in the development of novel therapies and personalised medicine. There are two major types of stem cells: adult and embryonic. Embryonic stem (ES) cells seem to possess a much higher therapeutic potential, due […]

Chemical Patent Applicationsip articles
18 May 2018

INPI Brazil Issues New Guidelines For Chemical Patent Applications

By Moeller IP Advisors According to data from the Chemical Abstract Service (CAS), a division of the American Chemical Society, the number of patents related to chemical products has grown tremendously in the last 20 years: the CAS Registry collects data on more than 132 million organic and inorganic substances. Brazil makes no exception to […]

counterfeit medicines in peruip articles
17 May 2018

The market of Counterfeit Medicines in Peru and the Legal tools to Combat it

By Moeller IP Advisors The market of counterfeit pharmaceuticals is probably the largest among all counterfeit goods, ranging from US$163 billion to $217 billion per year. Counterfeit medicines can include products with the wrong ingredients, without active ingredients, with insufficient active ingredients or with fake packaging. Peru is one of the main markets for counterfeit […]

Patent Prosecution Highway Programs in Brazilip articles
11 May 2018

Patent Prosecution Highway Programs in Brazil

By Moeller IP Advisors On February 1, 2018, the latest Patent Prosecution Highway Agreement signed by the Brazilian Institute for Intellectual Property (INPI Brazil) and the State Intellectual Property Office (SIPO) of China, came into force. The pilot program provides for an accelerated procedure for all patents filed in the field of Information Technology, packaging, […]

Domain names and trade disputes resolution in Argentinaip articles
01 May 2018

Domain names and trade disputes resolution in Argentina

By Moeller IP Advisors Cybersquatting, the practice of registering domain names using a small variation on a trademark’s name, has been on the rise in South America in the last years. Argentina makes no exception. In the country, registering a ccTLD domain name with the extension .com.ar, .org.ar, .net.ar etc. was free until 2014 – […]

Patenting Pharmaceutical Inventions in Colombiaip articles
26 Apr 2018

Patenting Pharmaceutical Inventions in Colombia

by Moeller IP Advisors In the latest years, Colombia has become an attractive market for pharmaceutical companies. According to a report from the consulting firm, Global Data, the value of the pharmaceutical market will rise from $5 billion in 2015 to $7.1 billion by 2020, with an astounding annual growth rate of 7.3%. The growth […]

Nanotechnology Patents in Brazilip articles
05 Apr 2018

Nanotechnology Investments and Nanotechnology Patents in Brazil

by Moeller IP Advisors Nanotechnology is the manipulation and production of materials and devices on the scale of atoms; through molecular manufacturing. In theory, any physical object could be reproduced in the laboratory. It is easy to note how the potential of nanotechnology could be immense, especially in the medical field, where nanotech developments can […]

bilogic drugsip articles
14 Sep 2017

Data Protection for Innovator Biologic Drugs in South America: the Case of Mexico

By Moeller IP Advisors Until 2016, 35,480 applications for patenting biological drugs were filed in Mexico, according to data provided by Innography, an IP consulting company.  It seems clear that Mexico constitutes a highly valued market for biologics. However, at this date, Mexico doesn’t have a law or another regulatory instrument that guarantees personal data […]

Moeller IP Advisors

Moeller IP